Trends in prescription opioid analgesic use in Australia from 2015 to 2022
Datos Bibliográficos
| ID | 14906802 |
|---|---|
| Autores | Kendal Chidwick (0000-0003-4901-4182, UNSW Sydney, autor de correspondencia), Chrianna Bharat (0000-0002-9778-0386, UNSW Sydney), Natasa Gisev (0000-0003-0452-8470, UNSW Sydney), Alys Havard (0000-0001-6563-8804, UNSW Sydney), Ximena Camacho (0000-0002-0755-3834, The University of Sydney), Sidney A Pearson (0000-0001-7137-6855, The University of Sydney), Louisa Degenhardt (0000-0002-8513-2218, UNSW Sydney) |
| Año | 2025 |
| Volumen | 135 |
| Páginas | 104666 |
| Fecha de publicación | 2025-01-01 |
| Peer Reviewed | Sí |
| Open Access | Sí |
| Tipo | ARTICLE |
| Revista | International Journal of Drug Policy (JOURNAL) |
| Identificadores de la revista | ISSN: 0955-3959 • E-ISSN: 1873-4758 |
| Editorial | Elsevier BV (PUBLISHER) |
| DOI | 10.1016/j.drugpo.2024.104666 |
| PMID | 39644755 |
| OpenAlex | W4405102107 |
| Idioma | EN |
| Referencias citadas | 19 |
Prescribed opioid analgesic use declined between 2015 and 2022 because of reductions in PBS dispensing claims. A quarter of the reduction in PBS dispensing claims was offset by use outside the PBS. Our findings indicate a significant increase in private use, reasons for which may include accessing opioids not PBS-subsidised and circumventing PBS restrictions for PBS-subsidised opioids. Comparing multiple data sources provides a comprehensive account of prescribed opioid analgesic use in Australia
Analgesic · Medical prescription · Opioid · Psychiatry · Receptor · Anesthesia and Pain Management · Medicine · Opioid Use Disorder Treatment · Pain Management and Opioid Use · Internal Medicine · Pharmacology
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |